Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity
1
x
$
30.00
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
1
x
$
30.00
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
1
x
$
30.00
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
1
x
$
30.00
Sophie Robert, PharmD - An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
1
x
$
30.00
View Cart
Checkout
Home
mary-w-brown
“Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
$
30.00
Add to cart
Details
Page load link
Go to Top
